176 related articles for article (PubMed ID: 38124732)
21. The genetics of type I interferon in systemic lupus erythematosus.
Bronson PG; Chaivorapol C; Ortmann W; Behrens TW; Graham RR
Curr Opin Immunol; 2012 Oct; 24(5):530-7. PubMed ID: 22889593
[TBL] [Abstract][Full Text] [Related]
22. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
Günther C; Berndt N; Wolf C; Lee-Kirsch MA
JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
[TBL] [Abstract][Full Text] [Related]
23. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
24. cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
Xiao N; Wei J; Xu S; Du H; Huang M; Zhang S; Ye W; Sun L; Chen Q
J Autoimmun; 2019 Jun; 100():84-94. PubMed ID: 30872080
[TBL] [Abstract][Full Text] [Related]
25. Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.
Ramírez-Vélez G; Medina F; Ramírez-Montaño L; Zarazúa-Lozada A; Hernández R; Llorente L; Moreno J
PLoS One; 2012; 7(7):e41414. PubMed ID: 22859983
[TBL] [Abstract][Full Text] [Related]
26. Rare variants in the TREX1 gene and susceptibility to autoimmune diseases.
Barizzone N; Monti S; Mellone S; Godi M; Marchini M; Scorza R; Danieli MG; D'Alfonso S
Biomed Res Int; 2013; 2013():471703. PubMed ID: 24224166
[TBL] [Abstract][Full Text] [Related]
27. A novel JAK/ROCK inhibitor, CPL409116, demonstrates potent efficacy in the mouse model of systemic lupus erythematosus.
Dulak-Lis M; Bujak A; Gala K; Banach M; Kędzierska U; Miszkiel J; Hucz-Kalitowska J; Mroczkiewicz M; Stypik B; Szymczak K; Gunerka P; Dubiel K; Zygmunt BM; Wieczorek M; Pieczykolan JS
J Pharmacol Sci; 2021 Apr; 145(4):340-348. PubMed ID: 33712286
[TBL] [Abstract][Full Text] [Related]
28. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.
Orebaugh CD; Fye JM; Harvey S; Hollis T; Perrino FW
J Biol Chem; 2011 Nov; 286(46):40246-54. PubMed ID: 21937424
[TBL] [Abstract][Full Text] [Related]
29. The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
Goropevšek A; Holcar M; Avčin T
Clin Rev Allergy Immunol; 2017 Apr; 52(2):164-181. PubMed ID: 27216430
[TBL] [Abstract][Full Text] [Related]
30. Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based review.
Abduelmula A; Sood S; Mufti A; Hinek A; Yeung J
J Am Acad Dermatol; 2023 Jul; 89(1):130-131. PubMed ID: 36935014
[No Abstract] [Full Text] [Related]
31. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
Front Immunol; 2021; 12():747616. PubMed ID: 34745118
[TBL] [Abstract][Full Text] [Related]
32. Type I interferon and systemic lupus erythematosus.
Elkon KB; Stone VV
J Interferon Cytokine Res; 2011 Nov; 31(11):803-12. PubMed ID: 21859344
[TBL] [Abstract][Full Text] [Related]
33. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Wallace DJ; Furie RA; Tanaka Y; Kalunian KC; Mosca M; Petri MA; Dörner T; Cardiel MH; Bruce IN; Gomez E; Carmack T; DeLozier AM; Janes JM; Linnik MD; de Bono S; Silk ME; Hoffman RW
Lancet; 2018 Jul; 392(10143):222-231. PubMed ID: 30043749
[TBL] [Abstract][Full Text] [Related]
34. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing.
Ellyard JI; Jerjen R; Martin JL; Lee AY; Field MA; Jiang SH; Cappello J; Naumann SK; Andrews TD; Scott HS; Casarotto MG; Goodnow CC; Chaitow J; Pascual V; Hertzog P; Alexander SI; Cook MC; Vinuesa CG
Arthritis Rheumatol; 2014 Dec; 66(12):3382-6. PubMed ID: 25138095
[TBL] [Abstract][Full Text] [Related]
35. Novel JAK inhibitors under investigation for systemic lupus erythematosus: - where are we now?
Nakayamada S; Tanaka Y
Expert Opin Investig Drugs; 2023; 32(10):901-908. PubMed ID: 37753834
[TBL] [Abstract][Full Text] [Related]
36. Catalytically Impaired TYK2 Variants are Protective Against Childhood- and Adult-Onset Systemic Lupus Erythematosus in Mexicans.
Contreras-Cubas C; García-Ortiz H; Velázquez-Cruz R; Barajas-Olmos F; Baca P; Martínez-Hernández A; Barbosa-Cobos RE; Ramírez-Bello J; López-Hernández MA; Svyryd Y; Mutchinick OM; Baca V; Orozco L
Sci Rep; 2019 Aug; 9(1):12165. PubMed ID: 31434951
[TBL] [Abstract][Full Text] [Related]
37. Refractory alopecia in lupus treated with tofacitinib - a case-based review.
Sarkar R; Mv P; Hinduja N; Sethy M; Kar H; Ahmed S
Clin Rheumatol; 2023 Aug; 42(8):2237-2241. PubMed ID: 37188961
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
Lee-Kirsch MA; Gong M; Chowdhury D; Senenko L; Engel K; Lee YA; de Silva U; Bailey SL; Witte T; Vyse TJ; Kere J; Pfeiffer C; Harvey S; Wong A; Koskenmies S; Hummel O; Rohde K; Schmidt RE; Dominiczak AF; Gahr M; Hollis T; Perrino FW; Lieberman J; Hübner N
Nat Genet; 2007 Sep; 39(9):1065-7. PubMed ID: 17660818
[TBL] [Abstract][Full Text] [Related]
39. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
Yi C; Li Q; Xiao J
Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
[TBL] [Abstract][Full Text] [Related]
40. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.
Sarkar MK; Hile GA; Tsoi LC; Xing X; Liu J; Liang Y; Berthier CC; Swindell WR; Patrick MT; Shao S; Tsou PS; Uppala R; Beamer MA; Srivastava A; Bielas SL; Harms PW; Getsios S; Elder JT; Voorhees JJ; Gudjonsson JE; Kahlenberg JM
Ann Rheum Dis; 2018 Nov; 77(11):1653-1664. PubMed ID: 30021804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
